Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor

Journal of Viral Hepatitis

Volumn 15, Issue 12, 2008, Pages 865-870

  Regeard M ^b   Trotard, M ^b   Lepere C ^b   Gripon, P ^b   Le Seyec, J ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Entry; Hepatitis C virus; Hepatocyte; SRBI

Indexed keywords

NEUTRALIZING ANTIBODY; SCAVENGER RECEPTOR BI;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; HEPATITIS C; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRAL GENE DELIVERY SYSTEM; VIRUS ENTRY;

CELLS, CULTURED; DOWN-REGULATION; GENE EXPRESSION; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; SCAVENGER RECEPTORS, CLASS B; VIRUS INTERNALIZATION;

EID: 56549098864     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.01048.x     Document Type: Article

References (46)

1. Helle F, Dubuisson J. Hepatitis C virus entry into host cells. Cell Mol Life Sci 2008 65 (1 100 112.
2. von Hahn T, Rice CM. Hepatitis C virus entry. J Biol Chem 2008 283 (7 3689 3693.
3. Koutsoudakis G, Kaul A, Steinmann E et al. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J Virol 2006 80 (11 5308 5320.
4. Molina S, Castet V, Fournier-Wirth C et al. The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J Hepatol 2007 46 (3 411 419.
5. Bartosch B, Vitelli A, Granier C et al. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 2003 278 (43 41624 41630.
6. Catanese MT, Graziani R, von Hahn T et al. High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. J Virol 2007 81 (15 8063 8071.
7. Grove J, Huby T, Stamataki Z et al. Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. J Virology 2007 81 (7 3162 3169.
8. Kapadia SB, Barth H, Baumert T, McKeating JA, Chisari FV. Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J Virol 2007 81 (1 374 383.
9. Lavillette D, Tarr AW, Voisset C et al. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 2005 41 (2 265 274.
10. Scarselli E, Ansuini H, Cerino R et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 2002 21 (19 5017 5025.
11. Zeisel MB, Koutsoudakis G, Schnober EK et al. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology 2007 46 (6 1722 1731.
12. Bartosch B, Dubuisson J, Cosset FL. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 2003 197 (5 633 642.
13. Cormier EG, Tsamis F, Kajumo F, Durso RJ, Gardner JP, Dragic T. CD81 is an entry coreceptor for hepatitis C virus. Proc Natl Acad Sci USA 2004 101 (19 7270 7274.
14. Hsu M, Zhang J, Flint M et al. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA 2003 100 (12 7271 7276.
15. Lindenbach BD, Evans MJ, Syder AJ et al. Complete replication of hepatitis C virus in cell culture. Science 2005 309 (5734 623 626.
16. Molina S, Castet V, Pichard-Garcia L et al. Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent. J Virol 2008 82 (1 569 574.
17. Pileri P, Uematsu Y, Campagnoli S et al. Binding of hepatitis C virus to CD81. Science 1998 282 (5390 938 941.
18. Wakita T, Pietschmann T, Kato T et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005 11 (7 791 796.
19. Zhong J, Gastaminza P, Cheng G et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005 102 (26 9294 9299.
20. Evans MJ, von Hahn T, Tscherne DM et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007 446 (7137 801 805.
21. Meertens L, Bertaux C, Cukierman L et al. The tight junction proteins claudin-1, -6 and -9 are entry cofactors for the Hepatitis C virus. J Virol 2008 82 (7 3555 3560.
22. Zheng A, Yuan F, Li Y et al. Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus. J Virol 2007 81 (22 12465 12471.
23. Blanchard E, Belouzard S, Goueslain L et al. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol 2006 80 (14 6964 6972.
24. Meertens L, Bertaux C, Dragic T. Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. J Virol 2006 80 (23 11571 11578.
25. Lavillette D, Bartosch B, Nourrisson D et al. Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes. J Biolog Chem 2006 281 (7 3909 3917.
26. Tscherne DM, Jones CT, Evans MJ, Lindenbach BD, McKeating JA, Rice CM. Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J Virol 2006 80 (4 1734 1741.
27. Bartosch B, Verney G, Dreux M et al. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J Virol 2005 79 (13 8217 8229.
28. Randall G, Panis M, Cooper JD et al. Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci USA 2007 104 (31 12884 12889.
29. Voisset C, Callens N, Blanchard E, Op De Beeck A, Dubuisson J, Vu-Dac N. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J Biolog Chem 2005 280 (9 7793 7799.
30. von Hahn T, Lindenbach BD, Boullier A et al. Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells. Hepatology 2006 43 (5 932 942.
31. Dreux M, Pietschmann T, Granier C et al. High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI. J Biolog Chem 2006 281 (27 18285 18295.
32. Meunier JC, Engle RE, Faulk K et al. Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc Natl Acad Sci USA 2005 102 (12 4560 4565.
33. Guguen-Guillouzo C, Guillouzo A. Methods for preparation of adult and fetal hepatocytes. In : Paris I, ed. Isolated and Cultured Hepatocytes. London, United Kingdom : John Libbey and Co., Ltd, 1986 : 1 12.
34. Dull T, Zufferey R, Kelly M et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998 72 (11 8463 8471.
35. Negre D, Mangeot PE, Duisit G et al. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther 2000 7 (19 1613 1623.
36. Rubinson DA, Dillon CP, Kwiatkowski AV et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 2003 33 (3 401 406.
37. Gripon P, Diot C, Theze N et al. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide. J Virol 1988 62 (11 4136 4143.
38. Rumin S, Berthillon P, Tanaka E et al. Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro. J Gen Virol 1999 80 (Pt 11 3007 3018.
39. Nguyen TH, Oberholzer J, Birraux J, Majno P, Morel P, Trono D. Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. Mol Ther 2002 6 (2 199 209.
40. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983 65 (1-2 55 63.
41. Bridge AJ, Pebernard S, Ducraux A, Nicoulaz AL, Iggo R. Induction of an interferon response by RNAi vectors in mammalian cells. Nature Genet 2003 34 (3 263 264.
42. Maillard P, Huby T, Andreo U, Moreau M, Chapman J, Budkowska A. The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins. FASEB J 2006 20 (6 735 737.
43. Lavie M, Voisset C, Vu-Dac N et al. Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system. Hepatology 2006 44 (6 1626 1634.
44. Webb NR, de Villiers WJ, Connell PM, de Beer FC, van der Westhuyzen DR. Alternative forms of the scavenger receptor BI (SR-BI). J Lipid Res 1997 38 (7 1490 1495.
45. Koutsoudakis G, Herrmann E, Kallis S, Bartenschlager R, Pietschmann T. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J Virol 2007 81 (2 588 598.
46. Barth H, Cerino R, Arcuri M et al. Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes. J Virol 2005 79 (9 5774 5785.